[1] Worner F,Cequier A,Alfredo Bardají,et al.ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J].European Heart Journal,2012,33(1):2569-619.
[2] Leistner D M,Fischer-Rasokat U,Jrg Honold,et al.Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy[J].Clinical Research in Cardiology,2011,100(10):925-934.
[3] Agyemang C, Van Oeffelen A A M,Bots M L,et al.Socioeconomic inequalities in acute myocardial infarction incidence in migrant groups: has the epidemic arrived? Analysis of nation-wide data[J].Heart,2014,100(3):239.
[4] 国家心血管病中心.中国心血管健康与疾病报告2019[M] .北京:科学出版社,2020.
[5] 苏懿,王磊,张敏州.急性心肌梗死的流行病学研究进展[J].中西医结合心脑血管病杂志,2012,10(4):467-469.
[6] 国家心血管病中心.中国心血管健康与疾病报告2019[M].北京:科学出版社,2020.
[7] Kook H Y,Jeong M H,Oh S,et al.Current Trend of Acute Myocardial Infarction in Korea (from the Korea Acute Myocardial Infarction Registry from 2006 to 2013)[J].American Journal of Cardiology, 2014,114(12):1817-1822.
[8] 李响,关文池,李冶铜,等.中国急性心肌梗死出院患者予以饮食建议/指导的情况及十年趋势调查[J].中华医学杂志,2018(7):544-548.
[9] Rosato V, Temple N J,La Vecchia C,et al.Mediterranean diet and cardiovascular disease: a systematic review and meta-analysis of observational studies[J].European Journal of Nutrition,2017,58(1):173-191.
[10] 王品晓,张云霞,项晓觉,等.急性冠脉综合征患者血尿酸水平变化及与同型半胱氨酸,T细胞亚群,血脂的关系研究[J].中华全科医学,2017,09(15):64-66.
[11] Witham W G,Yester K A,Mcgaffin K R.A high leucine diet mitigates cardiac injury and improves survival after acute myocardial infarction[J].Metabolism: clinical and experimental, 2013, 62(2):290-302.
[12] 李想,刘锐,王晓蕾,等.膳食补充亮氨酸对高脂喂养大鼠胰岛素敏感性的影响[A]. 中国疾病预防控制中心达能营养中心.营养与老年代谢病——达能营养中心第十四届学术年会论文集[C].中国疾病预防控制中心达能营养中心:中国疾病预防控制中心达能营养中心,2011:6.
[13] Margherita N,Vittorio F,Marco P,et al. Cardiac Oxidative STress and Inflammatory Cytokines Response after Myocardial Infarction[J].Current Vascular Pharmacology,2015,13(1):26-36.
[14] 杨震,傅旎旎, 薛慧文,等.瓜蒌皮对高血脂合并心肌缺血大鼠氧化应激状态动态调节作用研究[J].辽宁中医药大学学报,2018,20(01):39-43.
[15] Tao L,Bei Y, Lin S, et al.Exercise Training Protects Against Acute Myocardial Infarction via Improving Myocardial Energy Metabolism and Mitochondrial Biogenesis[J].Cellular Physiology and Biochemistry, 2015, 37(1):162-175.
[16] 杨飞云,孔令宇, 吴畏,等.青年急性心肌梗死危险因素及冠状动脉病变特点分析[J].新乡医学院学报,2018, 212(04):333-335339.
[17] Conwell D L,Lee L S,Yadav D, et al.American Pancreatic Association Practice Guidelines in Chronic Pancreatitis [J].Pancreas,2014,43(8):1143-1162.
[18] 肖蕾, 欧洋, 李京,等.100例急性心梗患者中医体质与证候的相关性研究[J].中国中医急症,2017,26(011):1891-1894.
[19] Reis L A,Chiu L L Y,Wu J,et al.Hydrogels with integrin-binding angiopoietin-1-derived peptide,QHREDGS,for treatment of acute myocardial infarction[J]. Circulation Heart Failure, 2015, 8(2):333-41.
[20] 钟国强,黄从新,刘唐威,等.不同类型冠心病的胰岛素抵抗及危险因素分析[J].中国医师进修杂志, 2000,023(012):11-13.
[21] Narayan H,Dhillon O,Quinn P,et al.C-terminal provasopressin (C肽) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study[J].Clinical Science,2011,121(2):79-89.
[22] 孙艺红,王桂莲,傅媛媛,等.床旁B型利钠肽检测与全球急性冠状动脉事件注册评分对急性冠状动脉综合征患者的预后价值[J].中华心血管病杂志,2009,37(8):716-720.
[23] 姜彬言,王高生,李婷婷,等.急性冠状动脉事件的全球性注册研究评分和校正改良式早期预警系统评分在急性心源性胸痛患者中的应用[J].中国临床保健杂志, 2017,20(5):505-508.
[24] 李琳,李芳,肖婷,等.冠心病患者血清活化T细胞趋化因子水平变化及与髓过氧化物酶、脂蛋白磷脂酶A2水平和全球急性冠状动脉事件注册评分的相关性[J].中国老年学,2016,36(3):585-587.
[25] Fujii T,Suzuki T,Torii S,et al.Diagnostic accuracy of Global Registry of Acute Coronary Events (GRACE) risk score in ST-elevation myocardial infarction for in-hospital and 360-day mortality in Japanese patients[J].Circulation Journal Official Journal of the Japanese Circulation Society,2014,78(12):2950-2954.
[26] Mckalip D,Harbaugh R E.Process measures and short-term mortality for acute myocardial infarction [J]. Jama the Journal of the American Medical Association, 2006, 296(21):2557-2558.
[27] 柯峰,左可可,顾宁.“冠心V号”制剂对急性心肌梗死模型大鼠心室重构及炎症因子的影响[J].中国中医基础医学杂志, 2016, v.22;No.233(01):50-53.
[28] 罗学军.C肽和超敏C反应蛋白水平对2型糖尿病患者心血管事件的预测价值分析[J].河南医学研究,2017, 26(7):1239-1241.
[29] 陈力,杨静.CK-MB、BNP、MYO、H-FABP及hs-cTnⅠ联合检测对早期急性心肌梗死的诊断价值[J].海南医学,2018.
[30] Glatz J F C,Vusse G J V D,Simoons M L,et al. Fatty acid-binding protein and the early detection of acute myocardial infarction[J].Clinica Chimica Acta, 1998, 272(1):87-92.
[31] Ip M S,Gottlieb J L,Kahana A,et al.Role of Heart-Type Fatty Acid Binding Protein in Early Detection of Acute Myocardial Infarction in Comparison with cTnI, CK-MB and Myoglobin[J]. Journal of Huazhong University of Science and Technology, 2004, 24(5):449-451.
[32] Herisson F,Delaroche O,Auffray-Calvier E, et al. Ischemia-modified Albumin and Heart Fatty Acid–binding Protein: Could Early Ischemic Cardiac Biomarkers Be Used in Acute STroke Management[J]. Journal of STroke & Cerebrovascular Diseases the Official Journal of National STroke Association, 2010, 19(4):279-282.
[33] 张蕾,黄丽敏,廖国平.血清缺血修饰白蛋白与心型脂肪酸结合蛋白联合检测在急性心肌梗死患者中的临床应用价值[J].吉林医学, 2020, 41(11):63-64.
[34] 郗汇聪,陈礴,候海文.联合检测血清脂肪酸结合蛋白和微小RNA-499在急性心肌梗死预警中的价值[J]. 中南医学科学杂志, 2020, 48(3):266-268.
[35] 金慧,乌日娜.早期心型脂肪酸结合蛋白与血栓弹力图联合检测对急性心肌梗死预后的评估价值[J]. 中国医刊, 2020, 55(2):45-48.
[36] Yarong W,Zhuangbo G,Liping H, et al.Value of different biochemical markers in early diagnosis of acute myocardial infarction [J]. Journal of Southern Medical University, 2014, 34(9):1347-1350.
[37] Bruins Slot M H E, Reitsma J B, Rutten F H,et al.Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction: a systematic review and meta-analysis[J]. Heart, 2011, 97(24):1957-1963.
[38] Okamoto F, Sohmiya K,Ohkaru Y,et al.Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB[J].Clinical Chemistry & Laboratory Medicine Cclm,2000,38(3):231-238.
[39] Tanaka T, Sohmiya K,Kitaura Y,et al.Clinical evaluation of point-of-care-testing of heart-type fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction.[J]. Journal of Immunoassay, 2006, 27(3):225-238.
[40] Jacobs L H, Borren M V,Gemen E,et al.ANNALS EXPRESS: Rapidly rule out acute myocardial infarction by combining C peptide and H-FABP with cardiac troponin[J]. Annals of Clinical Biochemistry, 2015, 52(5):143-148.
[41] Navarro C O, Kurth M J,Ruddock M,et al.An Algorithm Based on Combining hs-cTNT and H-FABP for Ruling Out Acute Myocardial Infarction[C]// 2019 Computing in Cardiology Conference. 2019.
[42] Claudia D, Merle T, Valerie S, et al.A novel H-FABP assay and a fast prognostic score for risk assessment of normotensive pulmonary embolism[J]. Thrombosis and Haemostasis, 2014, 111(5):996-1003.
[43] 薛炎,王立新,周帆,等.血清BNP,CK-MB,H-FABP水平早期动态检测对先心病合并肺炎患儿病情评估的临床价值[J].临床和实验医学杂志, 2020, 19(3):62-66.
[44] 赵巧凤,武国霞,郭秀芳,等.环磷酸腺苷葡胺联合冠心宁对老年冠心病合并充血性心力衰竭患者心功能及H-FABP的影响[J]. 河北医药, 2012, 34(20):3089-3090.
[45] 戴世荣,王兴山,邱谷,等.急性脑梗死患者血清H-FABP的动态变化及临床意义[J].现代检验医学杂志,2010,25(3):143-144.
[46] Meune C, Twerenbold R,Drexler B, et al.Midregional Pro-A-Type Natriuretic Peptide for Diagnosis and Prognosis in Patients With Suspected Acute Myocardial Infarction[J]. The American journal of cardiology, 2012, 109(8):1117-1123.
[47] 周保卫.心肌肌钙蛋白I,肌钙蛋白T和NT-proBNP联合检测急性心肌梗死的诊断价值探讨[J].当代医学,2015,21(17):42.
[48] 冯品宁,刘敏,崔颖鹏,等.心肌肌钙蛋白T、肌钙蛋白I及CK-MB诊断急性心肌梗死临床应用价值的比较分析[J].中国实验诊断学, 2008, 12(10):1256-1258.
[49] 王尧城,赖力,林赛梅,等.高敏肌钙蛋白Ⅰ浓度低于健康人群99百分位的非急性心肌梗死急诊胸痛患者的性别年龄调查[J].创伤与急诊电子杂志,2019,7(4):45-50.
[50] 郭慧佳,张建义,胡亚军,et al.高敏肌钙蛋白T与慢性心力衰竭的相关性及对急性心肌梗死的鉴别意义[J].中国全科医学,2014,33(8):871-874.
[51] Mb L C,Mb M T,Peacock W F.Undetectable hs-cTnT in the Emergency Department and Risk of Myocardial Infarction[J].Journal of the American College of Cardiology, 2014, 64(6):632-633.
[52] Ploner T,Mair J,Pachinger O,et al.Myocardial infarction diagnosis in the emergency department - highly sensitive cardiac Troponin T (hs-cTnT) is not superior to the 4th cTnT-Test Generation[J].Wiener klinische Wochenschrift, 2011, 123(17-18):A59-A60.
[53] 刘臣,宋莉,颜红兵,等.冠状动脉造影识别急性心肌梗死罪犯斑块类型价值的研究[J].中国介入心脏病学杂志,2019,27(5):243-248.
[54] 范丽译,刘士远校.心脏MRI评价急性心肌梗死后微血管阻塞和预测近期重塑的研究[J].国际医学放射学杂志,2009,32(2):184-185.
[55] 晏乘曦,常莹,任美吉,等.心肌应变力检测急性心肌梗死再灌注术后微循环障碍:基于特征追踪心脏MRI[J].放射学实践,2020,35(8):1025-1029.
[56] 张茵,杨跃进.急性心肌梗死心原性休克的诊断和治疗进展[J].中国循环杂志,2005,20(4):316-319.
[57] Bellandi B,Zocchi C,Xanthopoulou I,et al.Morphine use and myocardial reperfusion in patients with acute myocardial infarction treated with primary PCI[J]. International journal of cardiology, 2016,221:567-571.
[58] Everts B,Karlson B W,Herlitz J,et al.Morphine use and pharmacokinetics in patients with chest pain due to suspected or definite acute myocardial infarction[J]. European Journal of Pain, 2012,2(2):115-125.
[59] 刘磊,陶宁超,张梦遥,等.吗啡在急性心肌梗死中应用的新认识[J].中国心血管病研究,2019,17(4):316-320.
[60] 张艳红,张青,王娜,等.吗啡注射液在介入治疗急性心肌梗死病人中的临床疗效及药物安全性分析[J].中西医结合心脑血管病杂志, 2019, 17(11):1756-1758.
[61] 陈军,王万虹,张荣林,等.吸氧在急性心肌梗死患者行经皮冠状动脉介入治疗中的作用[J].中国临床医学,2015(3):322-326.
[62] 沈莹.急性心肌梗死病人缺氧性损伤及其吸氧护理[J].护士进修杂志,2003,4(10):902-903.
[63] 潘显芳.不同吸氧流量对急性心肌梗死缺氧性损伤的作用研究[J] .中国现代医学杂志, 2008, 18(21):3120-3122.
[64] Fosb l E L,Granger C B,Peterson E D,et al.Prehospital system delay in ST-segment elevation myocardial infarction care: A novel linkage of emergency medicine services and inhospital registry data[J].American Heart Journal,2013,165(3):363-370.
[65] Alhabib K F,Kadhim S,Jassim A S,et al.Patient and System-Related Delays of Emergency Medical Services Use in Acute ST-Elevation Myocardial Infarction:Results from the Third Gulf Registry of Acute Coronary Events (Gulf RACE-3Ps)[J]. Plos One,2016,11(1):1.
[66] Zhang S,Hu D,Wang X,et al.Use of Emergency Medical Services in Patients with Acute Myocardial Infarction in China[J].Clinical Cardiology,2010,32(3):137-141.
[67] Zalenski R J,Grzybowski M,Ross M A,et al.ECG scores for a triage of patients with acute myocardial infarction transported by the emergency medical system[J].Journal of Electrocardiology,2000,33(1):245-249.
[68] 陈维进,王雨来,王玉霞,等.基于信息管理系统的急性心梗医疗质量改进分析[J].中国卫生质量管理,2019,26(3):86-89.
[69] 陈会海,李毓忠,刘松岩.紧急医疗服务对急性心肌梗死患者不适当判断的影响[J].中国急救复苏与灾害医学杂志,2016,11(9): 906-909.
[70] 宋德明,孙爱娇,乔锐,等.急诊经皮冠状动脉介入治疗急性心肌梗死的临床疗效评估[J].安徽医学,2010,31(10):1166-1168.
[71] 胡静涛,李洪浩,等.探讨经皮冠状动脉介入治疗手术(PCI)及静脉溶栓两种治疗方式在急性心肌梗死患者中的临床疗效[J].中西医结合心血管病电子杂志,2014(9):1-2.
[72] 曲鹏,邓根群,李永旺,等.延迟经皮冠状动脉介入治疗对急性心肌梗死患者近期左心室重构及功能的影响[A]. 中华医学会心血管病学分会、中华医学会.国际介入心脏病学研讨会(CIT)暨全国介入心脏病学年会2004专辑[C].中华医学会心血管病学分会、中华医学会:中华医学会,2004:1.
[73] 邓兵, 刘萍. 直接经皮冠状动脉介入治疗急性心肌梗死的研究进展[J].西部中医药,2020,33(2):137-140.
[74] STenestrand U,Lindb ck J,Wallentin L,et al.Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction.[J]. Jama the Journal of the American Medical Association,2006,296(14):1749-56.
[75] Shavelle D M,Salami A,Abdelkarim M,et al.Rescue percutaneous coronary intervention for failed thrombolysis[J]. Catheterization & Cardiovascular Interventions, 2010, 67(2):214-220.
[76] Balachandran K P,Miller J,Pell A C H,et al.Rescue percutaneous coronary intervention for failed thrombolysis: results from a district general hospital[J].Postgraduate Medical Journal, 2002, 78(920):330.
[77] Testa L,Van G W J,Biondi-Zoccai G G L,et al.Repeat thrombolysis or conservative therapy vs. rescue percutaneous coronary intervention for failed thrombolysis: systematic review and meta-analysis[J].Qjm,2008(5):387-395. |
